Automated protein-ligand crystallography for structure-based drug design

被引:67
|
作者
Mooij, Wijnand T. M.
Hartshorn, Michael J.
Tickle, Ian J.
Sharff, Andrew J.
Verdonk, Marcel L.
Jhoti, Harren
机构
[1] Astex Therapeutics Ltd., Cambridge CB4 0QA
关键词
Drug design; Electron density fitting; Fragment-based drug discovery; Ligand fitting; Protein-ligand complexes; X-ray diffraction;
D O I
10.1002/cmdc.200600074
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An approach to automate protein-ligand crystallography is presented, with the aim of increasing the number of structures available to structure-based drug design. The methods we propose deal with the automatic interpretation of diffraction data for targets with known protein structures, and provide easy access to the results. Central to the system is a novel procedure that fully automates the placement of ligands into electron density maps. Automation provides on objective way to structure solution, whereas manual placement con be rather subjective, especially for data of low to medium resolution. Ligands are placed by docking into electron density, whilst taking care of protein-ligand interactions. The ligand fitting procedure has been validated on both public domain and in-house examples. Some of the latter deal with cocktails of low-molecular weight compounds, as used in fragment-based drug discovery by crystallography. For such library-screening experiments we show that the method can automatically identify which of the compounds from a cocktail is bound.
引用
收藏
页码:827 / 838
页数:12
相关论文
共 50 条
  • [1] Challenges, Applications, and Recent Advances of Protein-Ligand Docking in Structure-Based Drug Design
    Grinter, Sam Z.
    Zou, Xiaoqin
    [J]. MOLECULES, 2014, 19 (07) : 10150 - 10176
  • [2] Computational methods for calculation of protein-ligand binding affinities in structure-based drug design
    Dutkiewicz, Zbigniew
    [J]. PHYSICAL SCIENCES REVIEWS, 2022, 7 (09) : 933 - 968
  • [3] Methods for the prediction of protein-ligand binding sites for Structure-Based Drug Design and virtual ligand screening
    Laurie, Alasdair T. R.
    Jackson, Richard M.
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2006, 7 (05) : 395 - 406
  • [4] Characterising protein-ligand binding in support of structure-based drug discovery
    Murray, James
    Hubbard, Roderick E.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : C122 - C122
  • [5] Insight for structure-based drug design from the high-affinity protein-ligand reaction coordinate
    Stayton, PS
    Klumb, LA
    Freitag, S
    Chu, V
    Le Trong, I
    Chu, V
    Stenkamp, RE
    [J]. FASEB JOURNAL, 1997, 11 (09): : A830 - A830
  • [6] APLx-Automated Protein-Ligand Crystallography Workflow
    Pieritz, Romeu
    Leonard, Leonard
    McSweeney, Sean
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2009, 65 : S39 - S39
  • [7] MISATO: machine learning dataset of protein-ligand complexes for structure-based drug discovery
    Siebenmorgen, Till
    Menezes, Filipe
    Benassou, Sabrina
    Merdivan, Erinc
    Didi, Kieran
    Mourao, Andre Santos Dias
    Kitel, Radoslaw
    Lio, Pietro
    Kesselheim, Stefan
    Piraud, Marie
    Theis, Fabian J.
    Sattler, Michael
    Popowicz, Grzegorz M.
    [J]. NATURE COMPUTATIONAL SCIENCE, 2024, 4 (05): : 367 - 378
  • [8] Latest developments in crystallography and structure-based design of protein kinase inhibitors as drug candidates
    Williams, DH
    Mitchell, T
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (05) : 567 - 573
  • [9] PROTEIN STRUCTURE-BASED DRUG DESIGN
    WHITTLE, PJ
    BLUNDELL, TL
    [J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1994, 23 : 349 - 375
  • [10] Protein Crystallography and Structure Based Drug Design
    Johnson, L. N.
    Noble, M. E. M.
    Endicott, J. A.
    Watson, K. A.
    Oikonomakos, N. G.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2000, 56 : S95 - S95